- About About
Medical Patient Resources Becoming a State-Authorized Patient Talking to your doctor Which conditions qualify? The Medical Cannabis Patient’s Guide for U.S. Travel Patient's Guide to CBD Patient's Guide to Medical Cannabis Guide to Using Medical Cannabis Condition-based Booklets Growing Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Leaf411 Affordability Program Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources CME for Medical Professionals Cannabis Safety Medical Cannabis Research
- Legal Legal
Advocacy ASA Chapters Start an ASA Chapter Take Action Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
Policy Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Recognizing Science using the Data Quality Act Fact Sheet on ASA's Data Quality Act Petition to HHS Data Quality Act Briefs ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit Reports 2020 State of the States Medical Cannabis in America Medical Cannabis Access for Pain Treatment
- Join Join
Policy Recommendations Illinois
2019-2020 Improvements and Recommendations for Illinois
The most significant 2019 cannabis policy reforms were focused on establishing an adult-use commercial cannabis marketplace that opened in January 2020. Some patient-focused reforms to the state's medical program were also adopted, including making the state's medical cannabis access program permanent, initially authorized as a pilot in 2014, as well as the addition of 11 new qualifying conditions, including chronic pain. The state also passed Ashley's Law, which allows students to use medical cannabis under the supervision of certain school personnel while on school property.
Included in legislation authorizing commercial adult-use cannabis business licensing are provisions requiring existing medically licensed stores to maintain an adequate supply of cannabis and cannabis products for patients. ASA was pleased to see this provision included, as too often states fail to ensure the functionality of existing medical access systems and patient access prior to shifting focus to adult-use.
Under COVID emergency rules Illinois declared medical cannabis dispensaries essential, authorized curbside pickup and permitted patients to utilize telehealth screenings for program eligibility determinations rather than in-person visits with physicians.
ASA applauds the state for mandating geographic distribution of the original 55 medical cannabis facilities and hopes to see patient access expanded through the licensing of additional retail storefront in 2020. ASA also recommends reforming requirements for retail storefronts to maintain an ongoing and adequate supply of specific products to respond to frustration raised by patients over the inconsistency of product availability.